Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Introduces Microplate Mover Swap Out Program

Published: Friday, May 31, 2013
Last Updated: Friday, May 31, 2013
Bookmark and Share
Maximizing up-time for automated laboratory platforms.

Thermo Fisher Scientific Inc. has announced the introduction of its new Swap Out Program for the Thermo Scientific™ Orbitor® RS microplate mover, to maximize up-time in automated workflows.

One of the main advantages of laboratory automation is increased productivity. The Orbitor RS achieves this with rapid and flexible plate handling, allowing loading of multiple stacked or high-density instruments within a compact footprint.

Supporting the robust and reliable technology of the Orbitor RS, the Thermo Scientific Swap Out Program guarantees quick and efficient instrument replacement in the unlikely event that performance drops.

This unique approach ensures researchers can rely on benefiting from the full potential of automation. In contrast, systems sourced from alternative vendors could be sat idle and unproductive for perhaps days or even weeks, during the often lengthy process of diagnosis, repair or replacement.

With the Swap Out Program, a replacement Orbitor RS instrument is dispatched within just 24 hours of the Thermo Fisher Scientific Support Department logging the service call.

Technicians will then promptly co-ordinate a site visit for swap-out, and ensure the complete system is up-and-running in the following four hours.

Unlike alternative automated systems, data is now stored on the accompanying computer, instead of on memory boards within the Orbitor RS itself.

This development is what makes the Swap Out Program possible, as externally stored data prevents loss during instrument replacement and eliminates the need to reprogram a new machine.

With the Thermo Scientific Orbitor RS Swap Out Program, laboratories relying upon automated systems can now experience full confidence in continued productivity.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Completes Acquisition of Alfa Aesar
Thermo Fisher Scientific the world leader in serving science, has completed its previously announced acquisition of Alfa Aesar, a leading global manufacturer of research chemicals, from Johnson Matthey Plc, for £256 million (or approximately $400 million) in cash.
Friday, October 02, 2015
Thermo Fisher Scientific and Newman-Lakka Institute to Collaborate
The collaboration will research diagnostic approaches for personalized cancer treatment.
Tuesday, June 25, 2013
Scientific News
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!